May & Baker Nigeria Q1 2026 Board Meeting Date Announced

May & Baker Nigeria Plc has formally notified NGX of a scheduled board meeting on April 28, 2026, at which directors will consider and approve the company's unaudited financial statements for Q1 2026, covering the three months ended March 31, 2026. The notice, dated April 14, 2026, was filed in compliance with NGX Rules governing timely disclosure to the market.

A closed period — barring company insiders from trading in MAYBAKER shares — has been in force since April 1, 2026, and will only be lifted 24 hours after the accounts are formally submitted to the Exchange following the board sitting. This regulatory mechanism is designed to protect retail investors from information asymmetry, ensuring insiders cannot trade ahead of material financial disclosures.

For retail investors, the board meeting represents the first formal financial checkpoint of 2026 for the pharmaceutical and consumer healthcare company. Investors should watch for the Q1 2026 results once published on the NGX platform, paying close attention to revenue trends, profit margins, and any commentary on operating conditions.

The lifting of the closed period will confirm that results have been filed and are available for public review.